Tonix Pharmaceuticals Holding Corp. (TNXP) Press Releases https://ir.tonixpharma.com/news-events/press-releases/rss en-us https://s3.amazonaws.com/equisolve-dev4/tonixpharma/files/theme/images/logo-sm.png Tonix Pharmaceuticals Holding Corp. Logo Equisolve Investor Relations Suite <![CDATA[Tonix Pharmaceuticals Announces Publication of Clinical Pharmacokinetic Studies of TONMYA™ and Prototype Formulations in the Journal Clinical Pharmacology in Drug Development]]> https://ir.tonixpharma.com/news-events/press-releases/detail/1613/tonix-pharmaceuticals-announces-publication-of-clinical Thu, 05 Mar 26 16:15:00 -0500 https://ir.tonixpharma.com/news-events/press-releases/detail/1613/tonix-pharmaceuticals-announces-publication-of-clinical <![CDATA[Tonix Pharmaceuticals to Present Poster on Tonmya™ at the 2026 American Academy of Pain Medicine PainConnect Annual Meeting]]> https://ir.tonixpharma.com/news-events/press-releases/detail/1612/tonix-pharmaceuticals-to-present-poster-on-tonmya-at-the Tue, 03 Mar 26 16:30:00 -0500 https://ir.tonixpharma.com/news-events/press-releases/detail/1612/tonix-pharmaceuticals-to-present-poster-on-tonmya-at-the <![CDATA[Tonix Pharmaceuticals Announces Uplisting from Nasdaq Capital Market to Nasdaq Global Select Market]]> https://ir.tonixpharma.com/news-events/press-releases/detail/1611/tonix-pharmaceuticals-announces-uplisting-from-nasdaq Tue, 03 Mar 26 06:00:00 -0500 https://ir.tonixpharma.com/news-events/press-releases/detail/1611/tonix-pharmaceuticals-announces-uplisting-from-nasdaq <![CDATA[Tonix Pharmaceuticals to Participate in Two Investor Conferences in March]]> https://ir.tonixpharma.com/news-events/press-releases/detail/1610/tonix-pharmaceuticals-to-participate-in-two-investor Wed, 25 Feb 26 07:00:00 -0500 https://ir.tonixpharma.com/news-events/press-releases/detail/1610/tonix-pharmaceuticals-to-participate-in-two-investor <![CDATA[Tonix Pharmaceuticals Presented Phase 3 RESILIENT Data on TONMYA™ (Cyclobenzaprine HCl Sublingual Tablets) at the 2026 Non-Opioid Pain Therapeutics Summit]]> https://ir.tonixpharma.com/news-events/press-releases/detail/1609/tonix-pharmaceuticals-presented-phase-3-resilient-data-on Fri, 30 Jan 26 07:00:00 -0500 https://ir.tonixpharma.com/news-events/press-releases/detail/1609/tonix-pharmaceuticals-presented-phase-3-resilient-data-on <![CDATA[Tonix Pharmaceuticals to Present at Two Investor Conferences in January 2026]]> https://ir.tonixpharma.com/news-events/press-releases/detail/1608/tonix-pharmaceuticals-to-present-at-two-investor Tue, 06 Jan 26 07:00:00 -0500 https://ir.tonixpharma.com/news-events/press-releases/detail/1608/tonix-pharmaceuticals-to-present-at-two-investor <![CDATA[Tonix Pharmaceuticals Announces Pricing of $20.0 Million Registered Direct Offering]]> https://ir.tonixpharma.com/news-events/press-releases/detail/1607/tonix-pharmaceuticals-announces-pricing-of-20-0-million Mon, 29 Dec 25 07:57:00 -0500 https://ir.tonixpharma.com/news-events/press-releases/detail/1607/tonix-pharmaceuticals-announces-pricing-of-20-0-million <![CDATA[Tonix Pharmaceuticals Announces Program Updates on Phase 2/3-Ready Long-Acting Monoclonal Antibody (mAb) Designed for Seasonal Prevention of Lyme Disease (TNX-4800)]]> https://ir.tonixpharma.com/news-events/press-releases/detail/1606/tonix-pharmaceuticals-announces-program-updates-on-phase Mon, 29 Dec 25 07:45:00 -0500 https://ir.tonixpharma.com/news-events/press-releases/detail/1606/tonix-pharmaceuticals-announces-program-updates-on-phase <![CDATA[Tonix Pharmaceuticals Announces Licensing TNX-4900, a Selective Sigma-1 Receptor Antagonist for Chronic Neuropathic Pain from Rutgers University]]> https://ir.tonixpharma.com/news-events/press-releases/detail/1605/tonix-pharmaceuticals-announces-licensing-tnx-4900-a Tue, 16 Dec 25 07:00:00 -0500 https://ir.tonixpharma.com/news-events/press-releases/detail/1605/tonix-pharmaceuticals-announces-licensing-tnx-4900-a <![CDATA[Tonix Pharmaceuticals Appoints Irina Ishak as General Counsel]]> https://ir.tonixpharma.com/news-events/press-releases/detail/1604/tonix-pharmaceuticals-appoints-irina-ishak-as-general Tue, 09 Dec 25 07:00:00 -0500 https://ir.tonixpharma.com/news-events/press-releases/detail/1604/tonix-pharmaceuticals-appoints-irina-ishak-as-general